| UniProt ID | REBL1_HUMAN | |
|---|---|---|
| UniProt AC | Q8TAI7 | |
| Protein Name | GTPase RhebL1 | |
| Gene Name | RHEBL1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 183 | |
| Subcellular Localization |
Endomembrane system Lipid-anchor Cytoplasmic side . Cytoplasm . |
|
| Protein Description | Binds GTP and exhibits intrinsic GTPase activity. May activate NF-kappa-B-mediated gene transcription. Promotes signal transduction through MTOR, activates RPS6KB1, and is a downstream target of the small GTPase-activating proteins TSC1 and TSC2.. | |
| Protein Sequence | MPLVRYRKVVILGYRCVGKTSLAHQFVEGEFSEGYDPTVENTYSKIVTLGKDEFHLHLVDTAGQDEYSILPYSFIIGVHGYVLVYSVTSLHSFQVIESLYQKLHEGHGKTRVPVVLVGNKADLSPEREVQAVEGKKLAESWGATFMESSARENQLTQGIFTKVIQEIARVENSYGQERRCHLM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 107 | Ubiquitination | YQKLHEGHGKTRVPV HHHHHCCCCCCCCEE | 31.43 | 29967540 | |
| 109 | Ubiquitination | KLHEGHGKTRVPVVL HHHCCCCCCCCEEEE | 27.73 | 29967540 | |
| 118 | Ubiquitination | RVPVVLVGNKADLSP CCEEEEECCCCCCCH | 26.26 | 29967540 | |
| 120 | Ubiquitination | PVVLVGNKADLSPER EEEEECCCCCCCHHH | 37.03 | 29967540 | |
| 124 | Phosphorylation | VGNKADLSPEREVQA ECCCCCCCHHHHHHH | 25.84 | 24719451 | |
| 162 | Ubiquitination | LTQGIFTKVIQEIAR HHHHHHHHHHHHHHH | 26.96 | - | |
| 180 | Methylation | SYGQERRCHLM---- HCCCCCCCCCC---- | 3.46 | - | |
| 180 | Farnesylation | SYGQERRCHLM---- HCCCCCCCCCC---- | 3.46 | 16006564 | |
| 180 | Farnesylation | SYGQERRCHLM---- HCCCCCCCCCC---- | 3.46 | 16006564 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of REBL1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of REBL1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of REBL1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TRAF2_HUMAN | TRAF2 | physical | 20368287 | |
| DP13A_MOUSE | Appl1 | physical | 20368287 | |
| GO45_MOUSE | Blzf1 | physical | 20368287 | |
| TRAF2_MOUSE | Traf2 | physical | 20368287 | |
| TXN4A_HUMAN | TXNL4A | physical | 20368287 | |
| FHL3_HUMAN | FHL3 | physical | 21516116 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Prenylation | |
| Reference | PubMed |
| "The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib)inhibits Rheb farnesylation and mTOR signaling. Role in FTIenhancement of taxane and tamoxifen anti-tumor activity."; Basso A.D., Mirza A., Liu G., Long B.J., Bishop W.R., Kirschmeier P.; J. Biol. Chem. 280:31101-31108(2005). Cited for: TISSUE SPECIFICITY, AND ISOPRENYLATION AT CYS-180. | |